Sophia Randolph, Chief Medical Officer at ALX ONCOLOGY HOLDINGS INC (ALXO), sold 14,774 shares at $61.36 ($901K) on 2021-10-11, disclosed to the SEC on 2021-10-12.
Open-market sale of $901k ALXO by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.79 | 4,948 | $301K | 33.4% |
| 2 | $60.79 | 4,948 | $301K | 33.4% |
| 3 | $61.36 | 2,439 | $150K | 16.6% |
| 4 | $61.36 | 2,439 | $150K | 16.6% |
| Total | $60.98 avg | 14,774 | $901K | 100% |
| Filing → |
| ALXO | SELL | 2024-05-15 | $353K | — | Filing → |
| ALXO | SELL | 2024-01-03 | $47K | — | Filing → |
| ALXO | SELL | 2023-07-05 | $12K | — | Filing → |